• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成本:一个必须要问的重要问题。

Cost: An Important Question That Must Be Asked.

作者信息

Morgan R Andrew

机构信息

Neiswanger Institute for Bioethics, Loyola University Chicago, Chicago, IL, USA.

出版信息

HEC Forum. 2024 Mar;36(1):61-70. doi: 10.1007/s10730-022-09478-8. Epub 2022 Apr 21.

DOI:10.1007/s10730-022-09478-8
PMID:35445874
Abstract

Cost conversations are essential to informed consent because patients have a right to information that they think is relevant, and patients overwhelmingly report that cost information is relevant to their medical decisions. Providers have an ethical responsibility to provide necessary information for informed consent, and therefore must discuss costs. The Shared Decision Making model is ideal for enabling this exchange of information, and decision aids are also helpful. Although barriers exist, many useful tools can help providers fulfill this obligation, and encouraging progress is being made to improve cost transparency from insurers and facilities.

摘要

费用沟通对于知情同意至关重要,因为患者有权获取他们认为相关的信息,而且绝大多数患者报告称费用信息与他们的医疗决策相关。医疗服务提供者有道德责任提供必要信息以实现知情同意,因此必须讨论费用问题。共同决策模式非常适合促成这种信息交流,决策辅助工具也很有帮助。尽管存在障碍,但许多有用的工具可以帮助医疗服务提供者履行这一义务,而且在提高保险公司和医疗机构的费用透明度方面正在取得令人鼓舞的进展。

相似文献

1
Cost: An Important Question That Must Be Asked.成本:一个必须要问的重要问题。
HEC Forum. 2024 Mar;36(1):61-70. doi: 10.1007/s10730-022-09478-8. Epub 2022 Apr 21.
2
Money matters: a critique of 'informed financial consent'.金钱问题:对“知情财务同意”的批判。
Med Law Rev. 2024 Aug 1;32(3):356-372. doi: 10.1093/medlaw/fwae015.
3
Informed consent in gynecologic surgery.妇科手术中的知情同意。
Curr Opin Obstet Gynecol. 2019 Aug;31(4):240-244. doi: 10.1097/GCO.0000000000000550.
4
A typology of shared decision making, informed consent, and simple consent.共同决策、知情同意和简单同意的类型学
Ann Intern Med. 2004 Jan 6;140(1):54-9. doi: 10.7326/0003-4819-140-1-200401060-00012.
5
Can Consent to Participate in Clinical Research Involve Shared Decision Making?参与临床研究的同意可否涉及共同决策?
AMA J Ethics. 2020 May 1;22(5):E365-371. doi: 10.1001/amajethics.2020.365.
6
The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.健康素养干预措施对医疗保健使用者知情同意过程的有效性:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):82-94. doi: 10.11124/jbisrir-2015-2304.
7
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
8
"It's a mess sometimes": patient perspectives on provider responses to healthcare costs, and how informatics interventions can help support cost-sensitive care decisions.“有时一团糟”:患者对医疗服务提供者应对医疗费用的看法,以及信息学干预如何有助于支持对成本敏感的护理决策。
J Am Med Inform Assoc. 2022 May 11;29(6):1029-1039. doi: 10.1093/jamia/ocac010.
9
Informed Consent and Informed Decision-Making in High-Risk Surgery: A Quantitative Analysis.高风险手术中的知情同意和知情决策:定量分析。
J Am Coll Surg. 2021 Sep;233(3):337-345. doi: 10.1016/j.jamcollsurg.2021.05.029. Epub 2021 Jun 5.
10
Medical decision-making and communication of risks: an ethical perspective.医学决策与风险沟通:伦理视角。
J Med Ethics. 2010 Jun;36(6):349-52. doi: 10.1136/jme.2009.033282. Epub 2010 May 28.

本文引用的文献

1
Clinical Decision Making: Communicating Risk and Engaging Patients in Shared Decision Making.临床决策:沟通风险并让患者参与共同决策。
Ann Intern Med. 2020 May 19;172(10):688-692. doi: 10.7326/M19-3495. Epub 2020 Apr 21.
2
Waste in the US Health Care System: Estimated Costs and Potential for Savings.美国医疗体系中的浪费:估计成本和节约潜力。
JAMA. 2019 Oct 15;322(15):1501-1509. doi: 10.1001/jama.2019.13978.
3
Association Between Health Insurance Literacy and Avoidance of Health Care Services Owing to Cost.健康保险素养与因费用而避免医疗服务之间的关联。
JAMA Netw Open. 2018 Nov 2;1(7):e184796. doi: 10.1001/jamanetworkopen.2018.4796.
4
User-Centered Design for Developing Interventions to Improve Clinician Recommendation of Human Papillomavirus Vaccination.以用户为中心的设计:开发干预措施以改善临床医生对人乳头瘤病毒疫苗接种的推荐
Perm J. 2017;21:16-191. doi: 10.7812/TPP/16-191.
5
What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits.医生和患者会讨论哪些策略来降低自付费用?对1755次门诊就诊中的成本节约策略进行分析。
Med Decis Making. 2016 Oct;36(7):900-10. doi: 10.1177/0272989X15626384. Epub 2016 Jan 19.
6
Financial Toxicity of Cancer Care: It's Time to Intervene.癌症治疗的财务毒性:是时候采取行动了。
J Natl Cancer Inst. 2015 Dec 11;108(5). doi: 10.1093/jnci/djv370. Print 2016 May.
7
Addressing the Financial Burden of Cancer Treatment: From Copay to Can't Pay.应对癌症治疗的经济负担:从自付费用到无力支付。
JAMA Oncol. 2015 Jun;1(3):273-4. doi: 10.1001/jamaoncol.2015.0423.
8
The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature.美国癌症治疗自付费用的影响:文献的批判性评价
Future Oncol. 2014 Nov;10(14):2189-99. doi: 10.2217/fon.14.130.
9
Overcoming barriers to discussing out-of-pocket costs with patients.克服与患者讨论自付费用的障碍。
JAMA Intern Med. 2014 Jun;174(6):849-50. doi: 10.1001/jamainternmed.2014.853.
10
Financial $ide Effects: why patients should be informed of costs.经济副作用:为何应让患者了解费用情况。
Hastings Cent Rep. 2014 May-Jun;44(3):41-7. doi: 10.1002/hast.312. Epub 2014 Apr 2.